Rep. Lisa C. McClain Sells Off Shares of Baxter International Inc. (NYSE:BAX)

Key Points

• Representative Lisa C. McClain sold shares of Baxter International (NYSE:BAX) worth between $1,001 and $15,000 on August 4th, as disclosed in a filing on September 12th.
• Baxter International recently reported a quarterly loss of $0.59 EPS, missing analysts' estimates, and set Q3 2025 guidance at 0.580-0.620 EPS.
• The company announced a quarterly dividend of $0.17 per share, with a yield of 2.8%, despite having a payout ratio of -226.67%.

Representative Lisa C. McClain (R-Michigan) recently sold shares of Baxter International Inc. NYSE: BAX. In a filing disclosed on September 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Baxter International stock on August 4th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $50,001 - $100,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of ACI Worldwide NASDAQ: ACIW on 8/19/2025.
• Purchased $1,001 - $15,000 in shares of HCA Healthcare NYSE: HCA on 8/19/2025.
• Sold $1,001 - $15,000 in shares of Amedisys NASDAQ: AMED on 8/18/2025.
• Purchased $1,001 - $15,000 in shares of Kite Realty Group Trust NYSE: KRG on 8/13/2025.
• Sold $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of JD.com NASDAQ: JD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of Trade Desk NASDAQ: TTD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of US Foods NYSE: USFD on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of Agree Realty NYSE: ADC on 8/13/2025.

Baxter International Price Performance

Shares of Baxter International stock traded down $0.66 during trading hours on Friday, reaching $23.03. The stock had a trading volume of 13,671,637 shares, compared to its average volume of 5,815,892. The stock's 50 day moving average is $24.98 and its 200 day moving average is $29.00. The firm has a market capitalization of $11.83 billion, a PE ratio of -76.77, a PEG ratio of 0.77 and a beta of 0.61. Baxter International Inc. has a twelve month low of $21.33 and a twelve month high of $39.57. The company has a current ratio of 2.30, a quick ratio of 1.49 and a debt-to-equity ratio of 1.30.

Baxter International (NYSE:BAX - Get Free Report) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 EPS for the quarter, missing analysts' consensus estimates of $0.60 by ($0.01). The company had revenue of $2.81 billion for the quarter, compared to analysts' expectations of $2.82 billion. Baxter International had a positive return on equity of 16.96% and a negative net margin of 1.42%.The firm's revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.68 EPS. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. Equities analysts expect that Baxter International Inc. will post 2.48 earnings per share for the current fiscal year.

Baxter International Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be given a $0.17 dividend. The ex-dividend date is Friday, August 29th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 3.0%. Baxter International's dividend payout ratio is -226.67%.

Institutional Investors Weigh In On Baxter International

A number of hedge funds have recently added to or reduced their stakes in BAX. Dodge & Cox lifted its holdings in Baxter International by 2.1% during the 1st quarter. Dodge & Cox now owns 51,458,925 shares of the medical instruments supplier's stock worth $1,761,439,000 after buying an additional 1,081,631 shares in the last quarter. ARGA Investment Management LP increased its position in shares of Baxter International by 52.5% in the 1st quarter. ARGA Investment Management LP now owns 1,327,946 shares of the medical instruments supplier's stock valued at $45,456,000 after purchasing an additional 457,345 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Baxter International by 11,821.6% in the 1st quarter. GAMMA Investing LLC now owns 387,689 shares of the medical instruments supplier's stock valued at $13,271,000 after purchasing an additional 384,437 shares during the last quarter. Sound Shore Management Inc. CT increased its position in shares of Baxter International by 13.7% in the 1st quarter. Sound Shore Management Inc. CT now owns 2,825,902 shares of the medical instruments supplier's stock valued at $96,731,000 after purchasing an additional 341,321 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Baxter International by 2.6% in the 2nd quarter. Geode Capital Management LLC now owns 12,882,960 shares of the medical instruments supplier's stock valued at $388,416,000 after purchasing an additional 326,652 shares during the last quarter. 90.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

BAX has been the subject of several research reports. Wells Fargo & Company dropped their price objective on shares of Baxter International from $33.00 to $24.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Citigroup dropped their price target on shares of Baxter International from $34.00 to $32.00 and set a "neutral" rating for the company in a research note on Wednesday, July 9th. UBS Group dropped their price target on shares of Baxter International from $35.00 to $24.00 and set a "neutral" rating for the company in a research note on Monday, August 4th. The Goldman Sachs Group cut shares of Baxter International from a "buy" rating to a "neutral" rating and set a $25.00 price target for the company. in a research note on Friday, August 1st. Finally, Evercore ISI dropped their price target on shares of Baxter International from $44.00 to $42.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $30.11.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.